A prospective cohort study on sustained effects of low-dose ecstasy use on the brain in new ecstasy users (Q48381656)

11 February 2018

title

A prospective cohort study on sustained effects of low-dose ecstasy use on the brain in new ecstasy users (English)

1 reference

11 February 2018

11

Wim van den Brink

1 reference

11 February 2018

Charles Majoie

8

object named as

Charles B L M Majoie

1 reference

11 February 2018

author name string

Maartje M L de Win

1

1 reference

11 February 2018

Liesbeth Reneman

2

1 reference

11 February 2018

Gerry Jager

3

1 reference

11 February 2018

Erik-Jan P Vlieger

4

1 reference

11 February 2018

Sílvia D Olabarriaga

5

1 reference

11 February 2018

Cristina Lavini

6

1 reference

11 February 2018

Ivo Bisschops

7

1 reference

11 February 2018

Jan Booij

9

1 reference

11 February 2018

Gerard J den Heeten

10

1 reference

11 February 2018

language of work or name

English

0 references

publication date

1 November 2006

1 reference

11 February 2018

published in

Neuropsychopharmacology

1 reference

11 February 2018

volume

32

1 reference

11 February 2018

issue

2

1 reference

11 February 2018

page(s)

458-470

1 reference

11 February 2018

An Inventory for Measuring Depression

cites work

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1301225

Functional cerebral imaging by susceptibility-contrast NMR.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1301225

Eddy current correction in diffusion-weighted imaging using pairs of images acquired with opposite diffusion gradient polarity

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1301225

Angry cognitive bias, trait aggression and impulsivity in substance users

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1301225

Triggering in quantitative diffusion imaging with single-shot EPI.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1301225

Long-term effects of 'ecstasy' abuse on the human brain studied by FDG PET.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1301225

A voxel-based PET investigation of the long-term effects of "Ecstasy" consumption on brain serotonin transporters.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1301225

Impulsivity, risk taking and recreational 'ecstasy' (MDMA) use.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1301225

Human pharmacology of 3,4-methylenedioxymethamphetamine ("ecstasy"): psychomotor performance and subjective effects

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1301225

Cerebral (1)H MRS alterations in recreational 3, 4-methylenedioxymethamphetamine (MDMA, "ecstasy") users

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1301225

Perfusion MRI and computerized cognitive test abnormalities in abstinent methamphetamine users

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1301225

Psychedelic drugs: the ups and downs of ecstasy

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1301225

Heroin-induced spongiform leukoencephalopathy: value of diffusion MR imaging

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1301225

Diffusion-weighted MRI and 99mTc-HMPAO SPECT in delayed relapsing type of carbon monoxide poisoning: evidence of delayed cytotoxic edema.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1301225

Serotonin in the regulation of brain microcirculation

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1301225

The hyperthermic and neurotoxic effects of ‘Ecstasy’ (MDMA) and 3,4 methylenedioxyamphetamine (MDA) in the Dark Agouti (DA) rat, a model of the CYP2D6 poor metabolizer phenotype

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1301225

Ischemic stroke: effects of etiology and patient age on the time course of the core apparent diffusion coefficient

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1301225

Proton magnetic resonance spectroscopy in ecstasy (MDMA) users.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1301225

Self-reported psychopathological symptoms in recreational ecstasy (MDMA) users are mainly associated with regular cannabis use: further evidence from a combined cross-sectional/longitudinal investigation

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1301225

Psychological profile of abstinent recreational Ecstasy (MDMA) users and significance of concomitant cannabis use.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1301225

The Netherlands XTC Toxicity (NeXT) study: objectives and methods of a study investigating causality, course, and clinical relevance.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1301225

Ecstasy use and self-reported depression, impulsivity, and sensation seeking: a prospective cohort study

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1301225

The psychological and physiological effects of MDMA on normal volunteers.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1301225

Personality dimensions and psychopathological profiles of Ecstasy users

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1301225

3,4-Methylenedioxymethamphetamine (MDMA) modulates cortical and limbic brain activity as measured by [H(2)(15)O]-PET in healthy humans

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1301225

A review of the mechanisms involved in the acute MDMA (ecstasy)-induced hyperthermic response

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1301225

Subjective reports of the effects of MDMA in a clinical setting.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1301225

21 January 2018

The Politics of Ecstasy

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1301225

The Rician distribution of noisy MRI data

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1301225

Test-retest reliability of DSC MRI CBV mapping in healthy volunteers.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1301225

Acute and long-term consequences of single MDMA administration in relation to individual anxiety levels in the rat.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1301225

Diffusion-tensor MR imaging at 1.5 and 3.0 T: initial observations

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1301225

Abnormal cerebral perfusion in chronic methamphetamine abusers: a study using 99MTc-HMPAO and SPECT.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1301225

Toxic effect of MDMA on brain serotonin neurons

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1301225

The self-medication hypothesis of substance use disorders: a reconsideration and recent applications

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1301225

How strong is the evidence that brain serotonin neurons are damaged in human users of ecstasy?

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1301225

Frontal white matter biochemical abnormalities in late-life major depression detected with proton magnetic resonance spectroscopy

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1301225

‘Ecstasy’-induced subarachnoid haemorrhage: an under-reported neurological complication?

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1301225

Applications of dynamic susceptibility contrast magnetic resonance imaging in Neuropsychiatry

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1301225

Acute psychological effects of 3,4-methylenedioxymethamphetamine (MDMA, "Ecstasy") are attenuated by the serotonin uptake inhibitor citalopram

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1301225

Acute psychological and physiological effects of MDMA ("Ecstasy") after haloperidol pretreatment in healthy humans

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1301225

The serotonin uptake inhibitor citalopram reduces acute cardiovascular and vegetative effects of 3,4-methylenedioxymethamphetamine ('Ecstasy') in healthy volunteers.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1301225

Neuropsychiatric applications of DTI - a review

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1301225

(+/-)3,4-Methylenedioxymethamphetamine ('Ecstasy')-induced serotonin neurotoxicity: clinical studies

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1301225

Caveat emptor: editors beware

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1301225

Positron emission tomographic evidence of toxic effect of MDMA ("Ecstasy") on brain serotonin neurons in human beings

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1301225

Diversity of psychopathology associated with use of 3,4-methylenedioxymethamphetamine ('Ecstasy')

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1301225

Pharmacokinetic profile of single and repeated oral doses of MDMA in squirrel monkeys: relationship to lasting effects on brain serotonin neurons

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1301225

In vivo 1H MRS choline: correlation with in vitro chemistry/histology

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1301225

Recreational use of "ecstasy" (MDMA) is associated with elevated impulsivity.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1301225

Ecstasy (MDMA): a review of its possible persistent psychological effects

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1301225

Neuronal damage in the interval form of CO poisoning determined by serial diffusion weighted magnetic resonance imaging plus 1H-magnetic resonance spectroscopy

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1301225

Low N-acetyl-aspartate and high choline in the anterior cingulum of recently abstinent methamphetamine-dependent subjects: a preliminary proton MRS study. Magnetic resonance spectroscopy

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1301225

Specific neurotoxicity of chronic use of ecstasy

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1301225

5-HT receptors in human and animal cerebrovasculature

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1301225

Factor structure of the Barratt impulsiveness scale

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1301225

Regional metabolite concentrations in human brain as determined by quantitative localized proton MRS.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1301225

Effects of dose, sex, and long-term abstention from use on toxic effects of MDMA (ecstasy) on brain serotonin neurons

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1301225

Neuroimaging findings with MDMA/ecstasy: technical aspects, conceptual issues and future prospects

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1301225

Effects of ecstasy (MDMA) on the brain in abstinent users: initial observations with diffusion and perfusion MR imaging

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1301225

Prefrontal N-acetylaspartate is strongly associated with memory performance in (abstinent) ecstasy users: preliminary report

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1301225

Dynamic susceptibility contrast magnetic resonance imaging in neuropsychiatry: present utility and future promise

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1301225

Toxic effects of MDMA on central serotonergic neurons in the primate: importance of route and frequency of drug administration

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1301225

(+/-)3,4-Methylenedioxymethamphetamine ('Ecstasy')-induced serotonin neurotoxicity: studies in animals

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1301225

In vivo magnetic resonance spectroscopy of human brain: the biophysical basis of dementia

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1301225

No adjustments are needed for multiple comparisons

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1301225

Potential human neurotoxicity of MDMA ('Ecstasy'): subjective self-reports, evidence from an Italian drug addiction centre and clinical case studies

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1301225

Demonstration and localization of neuronal degeneration in the rat forebrain following a single exposure to MDMA

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1301225

Contribution of cytochrome P450 2D6 to 3,4-methylenedioxymethamphetamine disposition in humans: use of paroxetine as a metabolic inhibitor probe

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1301225

Fast robust automated brain extraction

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1301225

Advances in functional and structural MR image analysis and implementation as FSL

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1301225

A comparative study of myo-inositol quantification using LCmodel at 1.5 T and 3.0 T with 3 D 1H proton spectroscopic imaging of the human brain

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1301225

In vivo magnetic resonance spectroscopy and its application to neuropsychiatric disorders

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1301225

Self-reported depressive symptomatology in community samples of polysubstance misusers who report Ecstasy use: a meta-analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1301225

'Is MDMA a human neurotoxin?': diverse views from the discussants

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1301225

An "accidental" acute psychosis with ecstasy use.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1301225

Psychological and Cardiovascular Effects and Short-Term Sequelae of MDMA (“Ecstasy”) in MDMA-Naïve Healthy Volunteers

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1301225

Caveat emptor: editors beware

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1301225

Personality and risk-taking: common biosocial factors

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1301225

Diffusion tensor imaging in multiple sclerosis: a tool for monitoring changes in normal-appearing white matter

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1301225

Evidence for long-term neurotoxicity associated with methamphetamine abuse: A 1H MRS study

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1301225

Effect of ecstasy [3,4-methylenedioxymethamphetamine (MDMA)] on cerebral blood flow: a co-registered SPECT and MRI study

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1301225

7 January 2021

https://api.crossref.org/works/10.1038%2FSJ.NPP.1301225

1 reference

7 January 2021

Psychobiologic effects of 3,4-methylenedioxymethamphetamine in humans: methodological considerations and preliminary observations

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1301225

7 January 2021

Cerebral Infarction Associated with 3,4-Methylenedioxymethamphetamine (‘Ecstasy’) Abuse

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1301225

7 January 2021

Caveat emptor: researcher beware

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1301225

7 January 2021

Estimation of metabolite concentrations from localized in vivo proton NMR spectra

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1301225

7 January 2021

On the reliability of quantitative clinical magnetic resonance spectroscopy of the human brain

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1301225

7 January 2021

High Intensity Dependence of Auditory Evoked Dipole Source Activity Indicates Decreased Serotonergic Activity in Abstinent Ecstasy (MDMA) Users

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1301225

7 January 2021

Is a single dose of MDMA harmless?

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1301225

7 January 2021

Automated image registration: I. General methods and intrasubject, intramodality validation

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1301225

7 January 2021

Construct validity for the Sensation-Seeking Scale

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1301225

7 January 2021

Identifiers

DOI

10.1038/SJ.NPP.1301225

1 reference

11 February 2018

1 reference

11 February 2018